(Q74445959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

A K Rattan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Y Arad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

305-314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

Menopause and the risk of coronary heart disease in women

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

The impact of female sex hormones on secondary prevention of atherosclerosis in ovariectomized cholesterol-fed rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Protective effect of estrogens and catecholestrogens against peroxidative membrane damagein vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

The inhibition of low-density lipoprotein oxidation by 17-beta estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Estrogen replacement therapy and fatal ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Long term effects of tamoxifen on blood lipid values in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Oxidation of Low Density Lipoprotein Upon Sequential Exposure to Copper Ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

The relationship of natural androgens to coronary heart disease in males: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Continuous monitoring of in vitro oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Studies on the reduction of nitroblue tetrazolium chloride mediated through the action of NADH and phenazine methosulphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900229-3

10.1016/S0021-9150(97)00229-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9543102%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference